Both in Pharmaceuticals
Oric Pharmaceuticals vs Latigo Biotherapeutics
Over the past year ORIC returned −24.7% and LTGO returned −39.0%; their daily moves had a correlation of 0.07.
ORIC −24.7% LTGO −39.0%Growth of $1, one year, split-adjusted
| Metric | ORIC | LTGO |
|---|---|---|
| Price | $9.07 | $13.51 |
| Market cap | $940.1M | $895.7M |
| Today | −1.84% | −3.15% |
| 1 month | −25.7% | −15.0% |
| 6 months | −5.8% | — |
| Year to date | +10.9% | — |
| 1 year | −32.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $264.8M | — |
| Dividend yield | — | — |
| Volatility (60d) | 93.0% | — |
| Short % of float | 25.5% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).